erlotinib_hydrochloride  - Drug Details
📊 Estimates erlotinib_hydrochloride  Dialyzability By Different_Modalities

erlotinib_hydrochloride 

Complete Drug Information

Drug Name
erlotinib_hydrochloride 
Trade Names
Tarceva
Pregnancy Category
AU: C
Bioavailability
59%
Routes of Administration
Oral
Protein Binding
95%%
Metabolism
Liver (mainly CYP3A4, less CYP1A2)
Elimination
36.2 hrs (median)
Excretion
>98% as metabolites, of which >90% via feces, 9% via urine
Formula
C22H23N3O4
Molar Mass
393.443
Volume of Distribution
C22H23N3O4

🤰 Pregnancy Category Information

Category: AU: C

Drugs which, owing to their pharmacological effects, have caused or may be suspected of causing harmful effects on the human fetus or neonate without causing malformations. These effects may be reversible.